|
| Fei Teng | College of Life and Health Sciences, Northeastern University |
| Fei Teng | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Fei Teng | Brigham and Women's Hospital and Harvard Medical School |
| Fei Teng | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard School of Public Health |
| Wei Li | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard School of Public Health |
| Michaela Bowden | Dana-Farber Cancer Institute |
| Michaela Bowden | Brigham and Women's Hospital and Harvard Medical School |
| Rosina T Lis | Dana-Farber Cancer Institute |
| Rosina T Lis | Brigham and Women's Hospital and Harvard Medical School |
| Felix Y Feng | Michigan Center for Translational Pathology, Comprehensive Cancer Center, University of Michigan ann arbor |
| Felix Y Feng | University of Michigan ann arbor |
| Massimo Loda | Dana-Farber Cancer Institute |
| Massimo Loda | Brigham and Women's Hospital and Harvard Medical School |
| Massimo Loda | Dana-Farber Cancer Institute |
| Massimo Loda | Broad Institute of Harvard and MIT |
| Housheng Hansen He | Princess Margaret Cancer Center, University Health Network |
| Housheng Hansen He | University of Toronto |
| Xiaole Shirley Liu | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute and Harvard School of Public Health |
| Myles Brown | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Myles Brown | Brigham and Women's Hospital and Harvard Medical School |